HEADER TRANSPORT PROTEIN, RECEPTOR 10-MAY-16 5JTY TITLE GLUTAMATE- AND DCKA-BOUND GLUN1/GLUN2A AGONIST BINDING DOMAINS WITH TITLE 2 MPX-007 COMPND MOL_ID: 1; COMPND 2 MOLECULE: GLUTAMATE RECEPTOR IONOTROPIC, NMDA 1,GLUTAMATE RECEPTOR COMPND 3 IONOTROPIC, NMDA 1; COMPND 4 CHAIN: A; COMPND 5 FRAGMENT: UNP RESIDUES 415-565; 684-821; COMPND 6 SYNONYM: GLUN1,GLUTAMATE [NMDA] RECEPTOR SUBUNIT ZETA-1,N-METHYL-D- COMPND 7 ASPARTATE RECEPTOR SUBUNIT NR1,NMD-R1,GLUN1,GLUTAMATE [NMDA] RECEPTOR COMPND 8 SUBUNIT ZETA-1,N-METHYL-D-ASPARTATE RECEPTOR SUBUNIT NR1,NMD-R1; COMPND 9 ENGINEERED: YES; COMPND 10 MOL_ID: 2; COMPND 11 MOLECULE: GLUTAMATE RECEPTOR IONOTROPIC, NMDA 2A,GLUTAMATE RECEPTOR COMPND 12 IONOTROPIC, NMDA 2A; COMPND 13 CHAIN: B; COMPND 14 FRAGMENT: UNP RESIDUES 402-539; 661-800; COMPND 15 SYNONYM: GLUN2A,GLUTAMATE [NMDA] RECEPTOR SUBUNIT EPSILON-1,N-METHYL COMPND 16 D-ASPARTATE RECEPTOR SUBTYPE 2A,NR2A,GLUN2A,GLUTAMATE [NMDA] RECEPTOR COMPND 17 SUBUNIT EPSILON-1,N-METHYL D-ASPARTATE RECEPTOR SUBTYPE 2A,NR2A; COMPND 18 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: RATTUS NORVEGICUS; SOURCE 3 ORGANISM_COMMON: RAT; SOURCE 4 ORGANISM_TAXID: 10116; SOURCE 5 GENE: GRIN1, NMDAR1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: RATTUS NORVEGICUS; SOURCE 10 ORGANISM_COMMON: RAT; SOURCE 11 ORGANISM_TAXID: 10116; SOURCE 12 GENE: GRIN2A; SOURCE 13 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 14 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS NMDA RECEPTOR, ANTAGONIST, TRANSPORT PROTEIN, RECEPTOR EXPDTA X-RAY DIFFRACTION AUTHOR T.-C.MOU,S.R.SPRANG,K.B.HANSEN REVDAT 3 27-SEP-23 5JTY 1 JRNL REMARK REVDAT 2 05-OCT-16 5JTY 1 JRNL REVDAT 1 21-SEP-16 5JTY 0 JRNL AUTH F.YI,T.C.MOU,K.N.DORSETT,R.A.VOLKMANN,F.S.MENNITI, JRNL AUTH 2 S.R.SPRANG,K.B.HANSEN JRNL TITL STRUCTURAL BASIS FOR NEGATIVE ALLOSTERIC MODULATION OF JRNL TITL 2 GLUN2A-CONTAINING NMDA RECEPTORS. JRNL REF NEURON V. 91 1316 2016 JRNL REFN ISSN 0896-6273 JRNL PMID 27618671 JRNL DOI 10.1016/J.NEURON.2016.08.014 REMARK 2 REMARK 2 RESOLUTION. 2.72 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (1.10.1_2155: ???) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.72 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 14.97 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.400 REMARK 3 COMPLETENESS FOR RANGE (%) : 89.7 REMARK 3 NUMBER OF REFLECTIONS : 15867 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.230 REMARK 3 R VALUE (WORKING SET) : 0.224 REMARK 3 FREE R VALUE : 0.278 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1587 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 14.9733 - 5.9331 0.93 1437 160 0.1851 0.2135 REMARK 3 2 5.9331 - 4.7590 0.95 1397 156 0.1819 0.2412 REMARK 3 3 4.7590 - 4.1723 0.92 1340 148 0.1714 0.2397 REMARK 3 4 4.1723 - 3.7976 0.94 1364 152 0.1933 0.2405 REMARK 3 5 3.7976 - 3.5293 0.93 1343 150 0.2123 0.2937 REMARK 3 6 3.5293 - 3.3236 0.94 1354 150 0.2454 0.3054 REMARK 3 7 3.3236 - 3.1588 0.91 1293 144 0.2687 0.3197 REMARK 3 8 3.1588 - 3.0224 0.85 1215 135 0.2977 0.3576 REMARK 3 9 3.0224 - 2.9070 0.88 1258 140 0.3204 0.3601 REMARK 3 10 2.9070 - 2.8073 0.84 1206 134 0.3178 0.3873 REMARK 3 11 2.8073 - 2.7201 0.77 1073 118 0.3244 0.3740 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.430 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 28.250 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.002 4447 REMARK 3 ANGLE : 0.488 6011 REMARK 3 CHIRALITY : 0.042 662 REMARK 3 PLANARITY : 0.004 762 REMARK 3 DIHEDRAL : 16.501 2660 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5JTY COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 10-MAY-16. REMARK 100 THE DEPOSITION ID IS D_1000221226. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 22-JAN-16 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL9-2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.98 REMARK 200 MONOCHROMATOR : SI(111) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 15868 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.700 REMARK 200 RESOLUTION RANGE LOW (A) : 14.973 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 89.7 REMARK 200 DATA REDUNDANCY : 2.700 REMARK 200 R MERGE (I) : 0.17000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 6.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.70 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.75 REMARK 200 COMPLETENESS FOR SHELL (%) : 76.7 REMARK 200 DATA REDUNDANCY IN SHELL : 2.00 REMARK 200 R MERGE FOR SHELL (I) : 0.50000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.200 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 5I57 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.29 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.47 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2 M AMMONIUM SULFATE AND 16-22% PEG REMARK 280 4000, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 27.28450 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 65.20750 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 44.84200 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 65.20750 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 27.28450 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 44.84200 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2440 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 25380 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -6.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 1 REMARK 465 MET A 2 REMARK 465 SER A 3 REMARK 465 ASN A 48 REMARK 465 ASP A 49 REMARK 465 THR A 50 REMARK 465 SER A 51 REMARK 465 PRO A 52 REMARK 465 GLY A 53 REMARK 465 SER A 54 REMARK 465 PRO A 55 REMARK 465 ARG A 56 REMARK 465 ARG A 97 REMARK 465 VAL A 98 REMARK 465 ASN A 99 REMARK 465 ASN A 100 REMARK 465 SER A 101 REMARK 465 ASN A 102 REMARK 465 LYS A 152 REMARK 465 GLY A 153 REMARK 465 GLN A 234 REMARK 465 LYS A 235 REMARK 465 CYS A 236 REMARK 465 ASP A 237 REMARK 465 TYR A 287 REMARK 465 GLN A 288 REMARK 465 GLU A 289 REMARK 465 CYS A 290 REMARK 465 ASP A 291 REMARK 465 SER A 292 REMARK 465 SER B 4 REMARK 465 ASP B 5 REMARK 465 SER B 236 REMARK 465 GLY B 237 REMARK 465 TYR B 238 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN A 13 94.23 -160.72 REMARK 500 MET A 23 -169.42 -75.47 REMARK 500 ASN A 79 84.16 55.46 REMARK 500 PRO A 124 69.92 -67.03 REMARK 500 GLN A 178 13.15 59.28 REMARK 500 PHE A 246 72.97 56.40 REMARK 500 GLU B 16 99.01 -163.03 REMARK 500 LEU B 28 113.42 -162.15 REMARK 500 ARG B 34 -126.17 63.51 REMARK 500 LYS B 57 -157.83 -119.46 REMARK 500 LYS B 75 81.07 60.59 REMARK 500 LYS B 87 -108.78 -132.38 REMARK 500 ASN B 97 -165.62 -118.07 REMARK 500 ASN B 171 -16.75 73.53 REMARK 500 THR B 243 -132.97 -149.08 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 2JK A 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 6ND B 601 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GLU B 602 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5I57 RELATED DB: PDB REMARK 900 RELATED ID: 5I58 RELATED DB: PDB REMARK 900 RELATED ID: 5I59 RELATED DB: PDB REMARK 999 REMARK 999 SEQUENCE REMARK 999 THE SEQUENCE CORRESPONDS TO THE NCBI REFERENCE SEQUENCE NP_036705.3 REMARK 999 FOR GLUN2A. RESIDUE THR242 IN THIS SEQUENCE IS A SER758 IN SWISS- REMARK 999 PROT Q00959. DBREF 5JTY A 2 152 UNP P35439 NMDZ1_RAT 415 565 DBREF 5JTY A 155 292 UNP P35439 NMDZ1_RAT 684 821 DBREF 5JTY B 5 142 UNP Q00959 NMDE1_RAT 402 539 DBREF 5JTY B 145 284 UNP Q00959 NMDE1_RAT 661 800 SEQADV 5JTY GLY A 1 UNP P35439 EXPRESSION TAG SEQADV 5JTY GLY A 153 UNP P35439 LINKER SEQADV 5JTY THR A 154 UNP P35439 LINKER SEQADV 5JTY SER B 4 UNP Q00959 EXPRESSION TAG SEQADV 5JTY GLY B 143 UNP Q00959 LINKER SEQADV 5JTY THR B 144 UNP Q00959 LINKER SEQADV 5JTY THR B 242 UNP Q00959 SER 758 SEE REMARK 999 SEQRES 1 A 292 GLY MET SER THR ARG LEU LYS ILE VAL THR ILE HIS GLN SEQRES 2 A 292 GLU PRO PHE VAL TYR VAL LYS PRO THR MET SER ASP GLY SEQRES 3 A 292 THR CYS LYS GLU GLU PHE THR VAL ASN GLY ASP PRO VAL SEQRES 4 A 292 LYS LYS VAL ILE CYS THR GLY PRO ASN ASP THR SER PRO SEQRES 5 A 292 GLY SER PRO ARG HIS THR VAL PRO GLN CYS CYS TYR GLY SEQRES 6 A 292 PHE CYS ILE ASP LEU LEU ILE LYS LEU ALA ARG THR MET SEQRES 7 A 292 ASN PHE THR TYR GLU VAL HIS LEU VAL ALA ASP GLY LYS SEQRES 8 A 292 PHE GLY THR GLN GLU ARG VAL ASN ASN SER ASN LYS LYS SEQRES 9 A 292 GLU TRP ASN GLY MET MET GLY GLU LEU LEU SER GLY GLN SEQRES 10 A 292 ALA ASP MET ILE VAL ALA PRO LEU THR ILE ASN ASN GLU SEQRES 11 A 292 ARG ALA GLN TYR ILE GLU PHE SER LYS PRO PHE LYS TYR SEQRES 12 A 292 GLN GLY LEU THR ILE LEU VAL LYS LYS GLY THR ARG ILE SEQRES 13 A 292 THR GLY ILE ASN ASP PRO ARG LEU ARG ASN PRO SER ASP SEQRES 14 A 292 LYS PHE ILE TYR ALA THR VAL LYS GLN SER SER VAL ASP SEQRES 15 A 292 ILE TYR PHE ARG ARG GLN VAL GLU LEU SER THR MET TYR SEQRES 16 A 292 ARG HIS MET GLU LYS HIS ASN TYR GLU SER ALA ALA GLU SEQRES 17 A 292 ALA ILE GLN ALA VAL ARG ASP ASN LYS LEU HIS ALA PHE SEQRES 18 A 292 ILE TRP ASP SER ALA VAL LEU GLU PHE GLU ALA SER GLN SEQRES 19 A 292 LYS CYS ASP LEU VAL THR THR GLY GLU LEU PHE PHE ARG SEQRES 20 A 292 SER GLY PHE GLY ILE GLY MET ARG LYS ASP SER PRO TRP SEQRES 21 A 292 LYS GLN ASN VAL SER LEU SER ILE LEU LYS SER HIS GLU SEQRES 22 A 292 ASN GLY PHE MET GLU ASP LEU ASP LYS THR TRP VAL ARG SEQRES 23 A 292 TYR GLN GLU CYS ASP SER SEQRES 1 B 281 SER ASP ASP ASN HIS LEU SER ILE VAL THR LEU GLU GLU SEQRES 2 B 281 ALA PRO PHE VAL ILE VAL GLU ASP ILE ASP PRO LEU THR SEQRES 3 B 281 GLU THR CYS VAL ARG ASN THR VAL PRO CYS ARG LYS PHE SEQRES 4 B 281 VAL LYS ILE ASN ASN SER THR ASN GLU GLY MET ASN VAL SEQRES 5 B 281 LYS LYS CYS CYS LYS GLY PHE CYS ILE ASP ILE LEU LYS SEQRES 6 B 281 LYS LEU SER ARG THR VAL LYS PHE THR TYR ASP LEU TYR SEQRES 7 B 281 LEU VAL THR ASN GLY LYS HIS GLY LYS LYS VAL ASN ASN SEQRES 8 B 281 VAL TRP ASN GLY MET ILE GLY GLU VAL VAL TYR GLN ARG SEQRES 9 B 281 ALA VAL MET ALA VAL GLY SER LEU THR ILE ASN GLU GLU SEQRES 10 B 281 ARG SER GLU VAL VAL ASP PHE SER VAL PRO PHE VAL GLU SEQRES 11 B 281 THR GLY ILE SER VAL MET VAL SER ARG GLY THR GLN VAL SEQRES 12 B 281 THR GLY LEU SER ASP LYS LYS PHE GLN ARG PRO HIS ASP SEQRES 13 B 281 TYR SER PRO PRO PHE ARG PHE GLY THR VAL PRO ASN GLY SEQRES 14 B 281 SER THR GLU ARG ASN ILE ARG ASN ASN TYR PRO TYR MET SEQRES 15 B 281 HIS GLN TYR MET THR ARG PHE ASN GLN ARG GLY VAL GLU SEQRES 16 B 281 ASP ALA LEU VAL SER LEU LYS THR GLY LYS LEU ASP ALA SEQRES 17 B 281 PHE ILE TYR ASP ALA ALA VAL LEU ASN TYR LYS ALA GLY SEQRES 18 B 281 ARG ASP GLU GLY CYS LYS LEU VAL THR ILE GLY SER GLY SEQRES 19 B 281 TYR ILE PHE ALA THR THR GLY TYR GLY ILE ALA LEU GLN SEQRES 20 B 281 LYS GLY SER PRO TRP LYS ARG GLN ILE ASP LEU ALA LEU SEQRES 21 B 281 LEU GLN PHE VAL GLY ASP GLY GLU MET GLU GLU LEU GLU SEQRES 22 B 281 THR LEU TRP LEU THR GLY ILE CYS HET 2JK A 501 16 HET 6ND B 601 30 HET GLU B 602 10 HETNAM 2JK 4-HYDROXY-5,7-DIMETHYLQUINOLINE-2-CARBOXYLIC ACID HETNAM 6ND 5-({[(3,4-DIFLUOROPHENYL)SULFONYL]AMINO}METHYL)-6- HETNAM 2 6ND METHYL-N-[(2-METHYL-1,3-THIAZOL-5-YL)METHYL]PYRAZINE- HETNAM 3 6ND 2-CARBOXAMIDE HETNAM GLU GLUTAMIC ACID FORMUL 3 2JK C12 H11 N O3 FORMUL 4 6ND C18 H17 F2 N5 O3 S2 FORMUL 5 GLU C5 H9 N O4 FORMUL 6 HOH *81(H2 O) HELIX 1 AA1 GLY A 65 MET A 78 1 14 HELIX 2 AA2 ASN A 107 GLY A 116 1 10 HELIX 3 AA3 ASN A 128 GLN A 133 1 6 HELIX 4 AA4 ASP A 161 ASN A 166 1 6 HELIX 5 AA5 SER A 179 GLN A 188 1 10 HELIX 6 AA6 LEU A 191 LYS A 200 1 10 HELIX 7 AA7 SER A 205 ASP A 215 1 11 HELIX 8 AA8 SER A 225 SER A 233 1 9 HELIX 9 AA9 TRP A 260 ASN A 274 1 15 HELIX 10 AB1 GLY A 275 VAL A 285 1 11 HELIX 11 AB2 GLY B 61 VAL B 74 1 14 HELIX 12 AB3 ASN B 97 TYR B 105 1 9 HELIX 13 AB4 ASN B 118 GLU B 123 1 6 HELIX 14 AB5 ASP B 151 ARG B 156 1 6 HELIX 15 AB6 PRO B 157 TYR B 160 5 4 HELIX 16 AB7 GLY B 172 TYR B 182 1 11 HELIX 17 AB8 TYR B 182 THR B 190 1 9 HELIX 18 AB9 ARG B 191 ASN B 193 5 3 HELIX 19 AC1 GLY B 196 THR B 206 1 11 HELIX 20 AC2 ALA B 216 ARG B 225 1 10 HELIX 21 AC3 PRO B 254 ASP B 269 1 16 HELIX 22 AC4 GLY B 270 LEU B 280 1 11 SHEET 1 AA1 6 TYR A 18 PRO A 21 0 SHEET 2 AA1 6 VAL A 59 TYR A 64 -1 O TYR A 64 N TYR A 18 SHEET 3 AA1 6 VAL A 42 GLY A 46 -1 N VAL A 42 O CYS A 63 SHEET 4 AA1 6 TYR A 82 LEU A 86 1 O LEU A 86 N THR A 45 SHEET 5 AA1 6 LEU A 6 THR A 10 1 N LEU A 6 O GLU A 83 SHEET 6 AA1 6 MET A 120 ILE A 121 1 O MET A 120 N VAL A 9 SHEET 1 AA2 2 GLN A 95 GLU A 96 0 SHEET 2 AA2 2 GLU A 105 TRP A 106 -1 O GLU A 105 N GLU A 96 SHEET 1 AA3 2 ILE A 135 PHE A 137 0 SHEET 2 AA3 2 GLY A 253 ARG A 255 -1 O MET A 254 N GLU A 136 SHEET 1 AA4 4 TYR A 173 ALA A 174 0 SHEET 2 AA4 4 ALA A 220 ASP A 224 1 O ILE A 222 N ALA A 174 SHEET 3 AA4 4 LYS A 142 VAL A 150 -1 N THR A 147 O TRP A 223 SHEET 4 AA4 4 VAL A 239 PHE A 250 -1 O SER A 248 N GLN A 144 SHEET 1 AA5 8 ILE B 21 GLU B 23 0 SHEET 2 AA5 8 GLY B 52 LYS B 60 -1 O LYS B 60 N ILE B 21 SHEET 3 AA5 8 VAL B 37 LYS B 44 -1 N CYS B 39 O LYS B 57 SHEET 4 AA5 8 THR B 77 LEU B 82 1 O LEU B 82 N ARG B 40 SHEET 5 AA5 8 HIS B 8 THR B 13 1 N LEU B 9 O THR B 77 SHEET 6 AA5 8 MET B 110 ALA B 111 1 O MET B 110 N VAL B 12 SHEET 7 AA5 8 ALA B 248 LEU B 249 -1 O ALA B 248 N ALA B 111 SHEET 8 AA5 8 ASP B 126 PHE B 127 -1 N ASP B 126 O LEU B 249 SHEET 1 AA6 2 LYS B 91 VAL B 92 0 SHEET 2 AA6 2 VAL B 95 TRP B 96 -1 O VAL B 95 N VAL B 92 SHEET 1 AA7 4 PHE B 166 GLY B 167 0 SHEET 2 AA7 4 ALA B 211 ASP B 215 1 O ILE B 213 N GLY B 167 SHEET 3 AA7 4 VAL B 132 SER B 141 -1 N MET B 139 O PHE B 212 SHEET 4 AA7 4 LEU B 231 THR B 233 -1 O VAL B 232 N VAL B 140 SHEET 1 AA8 4 PHE B 166 GLY B 167 0 SHEET 2 AA8 4 ALA B 211 ASP B 215 1 O ILE B 213 N GLY B 167 SHEET 3 AA8 4 VAL B 132 SER B 141 -1 N MET B 139 O PHE B 212 SHEET 4 AA8 4 PHE B 240 TYR B 245 -1 O THR B 243 N THR B 134 SSBOND 1 CYS A 28 CYS A 62 1555 1555 2.03 SSBOND 2 CYS A 44 CYS A 63 1555 1555 2.03 SSBOND 3 CYS B 32 CYS B 58 1555 1555 2.04 SSBOND 4 CYS B 39 CYS B 59 1555 1555 2.03 SSBOND 5 CYS B 229 CYS B 284 1555 1555 2.03 CISPEP 1 GLU A 14 PRO A 15 0 3.87 CISPEP 2 ALA B 17 PRO B 18 0 1.72 CISPEP 3 LEU B 28 THR B 29 0 9.45 CISPEP 4 SER B 161 PRO B 162 0 -6.70 SITE 1 AC1 10 GLN A 13 PHE A 16 PHE A 92 PRO A 124 SITE 2 AC1 10 LEU A 125 THR A 126 ARG A 131 TRP A 223 SITE 3 AC1 10 VAL A 227 PHE A 250 SITE 1 AC2 14 PRO A 140 ARG A 247 SER A 248 GLY A 249 SITE 2 AC2 14 VAL B 129 PRO B 130 PHE B 131 VAL B 132 SITE 3 AC2 14 GLU B 133 LEU B 264 VAL B 267 MET B 272 SITE 4 AC2 14 GLU B 276 LEU B 280 SITE 1 AC3 11 HIS B 88 SER B 114 LEU B 115 THR B 116 SITE 2 AC3 11 ARG B 121 GLY B 172 SER B 173 THR B 174 SITE 3 AC3 11 TYR B 214 ASP B 215 HOH B 705 CRYST1 54.569 89.684 130.415 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.018325 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011150 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007668 0.00000